Nurture Pet Health Limited 05681662 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is the provision of veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true true false false false 05681662 2023-04-01 2024-03-31 05681662 2024-03-31 05681662 bus:OrdinaryShareClass1 2024-03-31 05681662 bus:OrdinaryShareClass2 2024-03-31 05681662 bus:OrdinaryShareClass3 2024-03-31 05681662 bus:OrdinaryShareClass4 2024-03-31 05681662 bus:OrdinaryShareClass5 2024-03-31 05681662 bus:OtherShareClass1 2024-03-31 05681662 core:AcceleratedTaxDepreciationDeferredTax 2024-03-31 05681662 core:TaxLossesCarry-forwardsDeferredTax 2024-03-31 05681662 core:CapitalRedemptionReserve 2024-03-31 05681662 core:RetainedEarningsAccumulatedLosses 2024-03-31 05681662 core:ShareCapital 2024-03-31 05681662 core:CurrentFinancialInstruments 2024-03-31 05681662 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 05681662 core:Non-currentFinancialInstruments 2024-03-31 05681662 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 05681662 core:Goodwill 2024-03-31 05681662 core:BetweenTwoFiveYears 2024-03-31 05681662 core:MoreThanFiveYears 2024-03-31 05681662 core:WithinOneYear 2024-03-31 05681662 core:ConstructionInProgressAssetsUnderConstruction 2024-03-31 05681662 core:FurnitureFittingsToolsEquipment 2024-03-31 05681662 core:LandBuildings 2024-03-31 05681662 core:MotorVehicles 2024-03-31 05681662 core:OtherPropertyPlantEquipment 2024-03-31 05681662 bus:SmallEntities 2023-04-01 2024-03-31 05681662 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 05681662 bus:FullAccounts 2023-04-01 2024-03-31 05681662 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 05681662 bus:RegisteredOffice 2023-04-01 2024-03-31 05681662 bus:Director1 2023-04-01 2024-03-31 05681662 bus:Director2 2023-04-01 2024-03-31 05681662 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 05681662 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 05681662 bus:OrdinaryShareClass3 2023-04-01 2024-03-31 05681662 bus:OrdinaryShareClass4 2023-04-01 2024-03-31 05681662 bus:OrdinaryShareClass5 2023-04-01 2024-03-31 05681662 bus:OtherShareClass1 2023-04-01 2024-03-31 05681662 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 05681662 core:Goodwill 2023-04-01 2024-03-31 05681662 core:ConstructionInProgressAssetsUnderConstruction 2023-04-01 2024-03-31 05681662 core:FurnitureFittings 2023-04-01 2024-03-31 05681662 core:FurnitureFittingsToolsEquipment 2023-04-01 2024-03-31 05681662 core:LandBuildings 2023-04-01 2024-03-31 05681662 core:LeaseholdImprovements 2023-04-01 2024-03-31 05681662 core:MotorVehicles 2023-04-01 2024-03-31 05681662 core:OfficeEquipment 2023-04-01 2024-03-31 05681662 core:OtherPropertyPlantEquipment 2023-04-01 2024-03-31 05681662 core:PlantMachinery 2023-04-01 2024-03-31 05681662 core:KeyManagementPersonnel 2023-04-01 2024-03-31 05681662 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-04-01 2024-03-31 05681662 core:Subsidiary1 2023-04-01 2024-03-31 05681662 core:Subsidiary1 countries:AllCountries 2023-04-01 2024-03-31 05681662 core:Subsidiary2 2023-04-01 2024-03-31 05681662 core:Subsidiary2 countries:AllCountries 2023-04-01 2024-03-31 05681662 countries:EnglandWales 2023-04-01 2024-03-31 05681662 2023-03-31 05681662 core:Goodwill 2023-03-31 05681662 core:CostValuation 2023-03-31 05681662 core:ConstructionInProgressAssetsUnderConstruction 2023-03-31 05681662 core:FurnitureFittingsToolsEquipment 2023-03-31 05681662 core:LandBuildings 2023-03-31 05681662 core:MotorVehicles 2023-03-31 05681662 core:OtherPropertyPlantEquipment 2023-03-31 05681662 2022-04-01 2023-03-31 05681662 2023-03-31 05681662 bus:OrdinaryShareClass1 2023-03-31 05681662 bus:OrdinaryShareClass2 2023-03-31 05681662 bus:OrdinaryShareClass3 2023-03-31 05681662 bus:OrdinaryShareClass4 2023-03-31 05681662 bus:OrdinaryShareClass5 2023-03-31 05681662 bus:OtherShareClass1 2023-03-31 05681662 core:AcceleratedTaxDepreciationDeferredTax 2023-03-31 05681662 core:TaxLossesCarry-forwardsDeferredTax 2023-03-31 05681662 core:CapitalRedemptionReserve 2023-03-31 05681662 core:RetainedEarningsAccumulatedLosses 2023-03-31 05681662 core:ShareCapital 2023-03-31 05681662 core:CurrentFinancialInstruments 2023-03-31 05681662 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 05681662 core:Non-currentFinancialInstruments 2023-03-31 05681662 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-31 05681662 core:Goodwill 2023-03-31 05681662 core:BetweenTwoFiveYears 2023-03-31 05681662 core:MoreThanFiveYears 2023-03-31 05681662 core:WithinOneYear 2023-03-31 05681662 core:ConstructionInProgressAssetsUnderConstruction 2023-03-31 05681662 core:FurnitureFittingsToolsEquipment 2023-03-31 05681662 core:LandBuildings 2023-03-31 05681662 core:MotorVehicles 2023-03-31 05681662 core:OtherPropertyPlantEquipment 2023-03-31 05681662 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 05681662 bus:OrdinaryShareClass2 2022-04-01 2023-03-31 05681662 bus:OrdinaryShareClass3 2022-04-01 2023-03-31 05681662 bus:OrdinaryShareClass4 2022-04-01 2023-03-31 05681662 bus:OrdinaryShareClass5 2022-04-01 2023-03-31 05681662 bus:OtherShareClass1 2022-04-01 2023-03-31 05681662 core:Subsidiary1 2022-04-01 2023-03-31 05681662 core:Subsidiary2 2022-04-01 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 05681662

Prepared for the registrar

Nurture Pet Health Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2024

 

Nurture Pet Health Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 13

 

Nurture Pet Health Limited

Company Information

Directors

C A Moore

S M Moore

Registered office

Westfield Vets
Westfield Road
Wells
BA5 2HS

Accountants

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

Nurture Pet Health Limited

(Registration number: 05681662)
Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Intangible assets

4

313,351

313,351

Tangible assets

5

1,992,282

1,601,273

Investments

6

200

200

 

2,305,833

1,914,824

Current assets

 

Stocks

80,786

87,409

Debtors

7

125,407

113,184

Cash at bank and in hand

 

16,314

18,834

 

222,507

219,427

Creditors: Amounts falling due within one year

8

(1,067,003)

(686,432)

Net current liabilities

 

(844,496)

(467,005)

Total assets less current liabilities

 

1,461,337

1,447,819

Creditors: Amounts falling due after more than one year

8

(1,280,885)

(1,330,933)

Deferred tax liabilities

9

(158,430)

(122,282)

Net assets/(liabilities)

 

22,022

(5,396)

Capital and reserves

 

Called up share capital

50

50

Capital redemption reserve

50

50

Profit and loss account

21,922

(5,496)

Shareholders' funds/(deficit)

 

22,022

(5,396)

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 23 August 2024 and signed on its behalf by:
 


C A Moore
Director

 

Nurture Pet Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Westfield Vets
Westfield Road
Wells
BA5 2HS
England

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

 

Nurture Pet Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Government grants

Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in income over the period in which the related costs are recognised. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Leasehold property

1% straight line / Over the length of the lease

Plant and machinery

10% straight line / 15% written down value

Fixtures and fittings

10% written down value

Office equipment

33% straight line

Motor vehicles

25% written down value

Investment property

Investment property is carried at fair value, derived from the current market prices for comparable real estate determined annually by external valuers. The valuers use observable market prices, adjusted if necessary for any difference in the nature, location or condition of the specific asset. Changes in fair value are recognised in revaluation surplus, with revaluation losses recognised in profit or loss.

 

Nurture Pet Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Goodwill

Goodwill is amortised over its useful life, which shall not exceed five years if a reliable estimate of the useful life cannot be made.

Intangible assets

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

 

Nurture Pet Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the Balance Sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the Profit and Loss Account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Nurture Pet Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was as follows:

 

Nurture Pet Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

 

4

Intangible assets

Goodwill
 £

Total
£

Cost

At 1 April 2023

365,497

365,497

At 31 March 2024

365,497

365,497

Amortisation

At 1 April 2023

52,146

52,146

At 31 March 2024

52,146

52,146

Carrying amount

At 31 March 2024

313,351

313,351

At 31 March 2023

313,351

313,351

 

Nurture Pet Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

 

5

Tangible assets

Land and buildings
£

Plant and machinery
 £

Motor vehicles
 £

Fixtures and fittings
 £

Office equipment
 £

Total
£

Cost

At 1 April 2023

1,383,981

163,656

46,435

235,333

24,827

1,854,232

Additions

196,580

160,785

17,333

75,527

3,034

453,259

Disposals

(21,553)

-

-

-

-

(21,553)

At 31 March 2024

1,559,008

324,441

63,768

310,860

27,861

2,285,938

Depreciation

At 1 April 2023

71,579

91,795

21,976

46,906

20,703

252,959

Charge for the year

196

25,791

8,937

24,851

2,475

62,250

Eliminated on disposal

(21,553)

-

-

-

-

(21,553)

At 31 March 2024

50,222

117,586

30,913

71,757

23,178

293,656

Carrying amount

At 31 March 2024

1,508,786

206,855

32,855

239,103

4,683

1,992,282

At 31 March 2023

1,312,402

71,861

24,459

188,427

4,124

1,601,273

Included within the net book value of land and buildings above is £941,649 (2023 - £865,133) in respect of freehold land and buildings, £23,163 (2023 - £16,761) in respect of leasehold land and buildings and £688,450 (2023 - £430,508) in respect of investment property.
 

 

Nurture Pet Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

 

6

Investments

2024
£

2023
£

Investments in subsidiaries

200

200

Subsidiaries

£

Cost

At 1 April 2023

200

Provision

Carrying amount

At 31 March 2024

200

At 31 March 2023

200

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

     

2024

2023

Subsidiary undertakings

Milsom Properties Ltd

Westfield Vets, Westfield Road, Wells, BA5 2HS

Ordinary

100%

100%

 

England

     

Summer Lane Vets Ltd

Westfield Vets, Westfield Road, Wells. BA5 2HS

Ordinary

100%

100%

 

England

     

Subsidiary undertakings

Milsom Properties Ltd

The principal activity of Milsom Properties Ltd is that of a dormant company.

Summer Lane Vets Ltd

The principal activity of Summer Lane Vets Ltd is that of a dormant company.

 

Nurture Pet Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

 

7

Debtors

2024
 £

2023
 £

Trade debtors

102,058

99,905

Other debtors

16,662

1,372

Prepayments

6,687

11,907

 

125,407

113,184

 

8

Creditors

Note

2024
 £

2023
 £

Due within one year

 

Loans and borrowings

10

446,937

416,628

Trade creditors

 

155,609

120,690

Social security and other taxes

 

161,535

125,882

Outstanding defined contribution pension costs

 

9,542

6,777

Other creditors

 

262,713

6,197

Accrued expenses

 

30,667

10,258

 

1,067,003

686,432

Due after one year

 

Loans and borrowings

10

1,280,885

1,330,933

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

10

1,280,885

1,330,933

 

9

Deferred tax

Deferred tax assets and liabilities

2024

Liability
£

Difference between accumulated depreciation and amortisation and capital allowances

170,064

Losses and other deductions

(11,634)

158,430

2023

Liability
£

Difference between accumulated depreciation and amortisation and capital allowances

134,575

Losses and other deductions

(12,293)

122,282

 

Nurture Pet Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

 

10

Loans and borrowings

2024
£

2023
£

Current loans and borrowings

Bank borrowings

137,576

117,813

Bank overdrafts

129,242

98,292

Hire purchase liabilities

17,907

-

Other borrowings

162,212

200,523

446,937

416,628

2024
£

2023
£

Non-current loans and borrowings

Bank borrowings

1,223,635

1,330,933

Hire purchase liabilities

57,250

-

1,280,885

1,330,933

 

11

Share capital

Allotted, called up and fully paid shares

 

2024

2023

 

No.

£

No.

£

Ordinary A of £0.50 (2023 - £1) each

60

30.00

25

25

Ordinary B of £0.50 (2023 - £1) each

20

10.00

15

15

Ordinary C of £0.50 (2023 - £1) each

5

2.50

10

10

Ordinary D of £0.50 (2023 - £0) each

5

2.50

-

-

Ordinary E of £0.50 (2023 - £0) each

5

2.50

-

-

Ordinary F of £0.50 (2023 - £0) each

5

2.50

-

-

 

100

50

50

50

On 5 July 2023 25 A, 15 B and 10 C Ordinary £1 shares were subdivided into 50 A, 30 B and 20 C Ordinary 50p shares. On 6 July 2023 10 B Ordinary 50p shares were reclassified as 10 A Ordinary 50p shares. On 14 July 2023 15 C Ordinary 50p shares were reclassified as 5 D, E and F Ordinary 50p shares.

The different classes of shares referred to above carry separate rights to dividends but, in all other significant respects, rank pari passu.

 

Nurture Pet Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

 

12

Financial commitments, guarantees and contingencies

Operating leases

The total of future minimum lease payments is as follows:

2024
 £

2023
 £

Not later than one year

31,542

23,000

Later than one year and not later than five years

100,542

92,000

Later than five years

172,500

195,500

304,584

310,500

 

13

Related party transactions

Key management personnel

Key management personnel are the directors of the company.

Summary of transactions with key management

As at the balance sheet date, the company owed the directors £162,212 (2023: £200,523). This amount is included within other borrowings. There are no fixed repayment terms and interest is charged on the outstanding amount.